Tech Company Financing Transactions

Enlaza Therapeutics Funding Round

On 12/19/2022, Enlaza Therapeutics landed $61 million in Seed funding from Avalon Ventures, Frazier Life Sciences and Lightspeed Venture Partners.

Transaction Overview

Announced On
12/19/2022
Transaction Type
Venture Equity
Amount
$61,000,000
Round
Seed
Proceeds Purpose
The company intends to use the funds to advance its proprietary War-Lock platform and build a pipeline of covalent biologics with an initial focus on developing novel, differentiated cancer therapeutics with targeted efficacy and low toxicity.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
11099 North Torrey Pines Rd 280
La Jolla, CA 92037
USA
Phone
Undisclosed
Email Address
Overview
Enlaza is creating a groundbreaking new class of protein therapeutics that deliver more efficacious and safer treatments for patients. Enlaza's breakthrough War-LockTM technology enables generation of unique, highly-selective biologic drugs that are engineered to become warheads with the capacity to irreversibly lock to disease related targets. We leverage our novel synthetic biology platform, coupled with proprietary amino acids, to precision-engineer biological medicines with improved efficacy and safety profiles.
Profile
Enlaza Therapeutics LinkedIn Company Profile
Social Media
Enlaza Therapeutics Company Twitter Account
Company News
Enlaza Therapeutics News
Facebook
Enlaza Therapeutics on Facebook
YouTube
Enlaza Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Sergio Duron
  Sergio Duron LinkedIn Profile  Sergio Duron Twitter Account  Sergio Duron News  Sergio Duron on Facebook
Chief Scientific Officer
Analeah Heidt
  Analeah Heidt LinkedIn Profile  Analeah Heidt Twitter Account  Analeah Heidt News  Analeah Heidt on Facebook
Co-Founder
Sanford Madigan
  Sanford Madigan LinkedIn Profile  Sanford Madigan Twitter Account  Sanford Madigan News  Sanford Madigan on Facebook
Vice President
Sergio Duron
  Sergio Duron LinkedIn Profile  Sergio Duron Twitter Account  Sergio Duron News  Sergio Duron on Facebook
Vice President
Emily Rowell
  Emily Rowell LinkedIn Profile  Emily Rowell Twitter Account  Emily Rowell News  Emily Rowell on Facebook


 

 

Browse more venture capital transactions:

Prev: 12/19/2022: Husslup venture capital transaction
Next: 12/19/2022: Pocketnest venture capital transaction

 

Share this article

 


About Our Venture Capital Transactions Database

Our team works diligently to document funding rounds that are announced publicly. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary